Proton Pump Inhibitor Legal News Articles & Interviews

Newark, NJ A wrongful death lawsuit has been filed against AstraZeneca, Merck & Co., Procter & Gamble and other manufacturers of proton pump inhibitor (PPI) drugs. Plaintiff Daisy Perez claims her husband, a New Mexico man, died of metastatic gastric cancer after taking Nexium and Prilosec.

Las Vegas, NV Proton Pump Inhibitor (PPI) manufacturers and distributors AstraZeneca and Merck are facing a wrongful death lawsuit alleging the side effects of Nexium caused stomach cancer, which lead to death.

New Jersey  If all goes according to Judge Cecchi’s plan, the pool of Proton Pump Inhibitor drugs (PPI) cases will have whittled down to six only – from a total of 32 potential bellwether cases by the end of January.

Santa Clara, CA Over the past several years, Proton Pump Inhibitors (PPI) have been linked to serious health complications. And more recent studies indicate that these acid reflux drugs do more harm than good. One such study opines that PPI exposure increases mortality in COVID-19 patients. Other studies suggest PPIs can damage major organs and regular use of PPI is linked to a higher risk of being diagnosed with type 2 diabetes and serious skin reactions such as life-threatening Stevens-Johnson Syndrome. And there is more…

Phoenix, AZ Ten years ago Gary Phillips was diagnosed with type 2 diabetes. He had taken proton pump inhibitor (PPI) medications for acid reflux issues at least once a day for about 13 years but only knew that the medications were linked to diabetes when he read about PPI lawsuits. Unfortunately the meds worked— so he kept taking them. Now he takes insulin shots.

Santa Clara, CA During this Pandemic there is also an epidemic that has been growing for decades and it is just as dangerous, perhaps even more so, than COVID 19. And drugs known as proton pump inhibitors or PPIs are feeding this epidemic: type 2 diabetes.

Santa Clara, CA: A link between proton pump inhibitors (PPIs) and high risk of gastric cancer isn’t new, but the results of a new study conflicts with the FDA’s mandated PPI study.

Newark, NJ: Heartburn, more correctly known as acid reflux, continues to be a common complaint affecting a vast cross section of the American population. Relief is often in the form of medication - and, specifically proton pump inhibitors such as Nexium, a product of AstraZeneca. Plaintiff Shirlene Bonner began regular use of Nexium to relieve heartburn from 2003 until 2015, until a diagnosis of chronic kidney disease (CKD) found her searching for answers as to what may have triggered her CKD. Bonner alleges in her PPI lawsuit that Nexium, a proton pump inhibitor, is the root cause.

Washington, DC: As many as 80 percent of expectant mothers suffer from heartburn or acid indigestion during pregnancy. Until recently proton pump inhibitors (PPIs), such as Nexium, Prilosec and Prevacid, were thought to be both effective for mom and safe for baby.

Washington, DC: The long-term use of drugs classed as proton pump inhibitors or PPIs , and marketed variously as Prevacid, Prilosec or Nexium, is dangerous for many reasons. Kidney damage, the focus of recently consolidated multidistrict litigation, is not the only problem. Long-term PPI use has also been associated with bone fractures and dementia in women, as well as the risk of birth defects. The issue for the lawsuits to come will be whether drug makers gave patients adequate warning of the dangers associated with their products and thus the opportunity to make informed choices.